Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) EV to FCF (2018 - 2026)

Dyadic International's (DYAI) quarterly EV to FCF came in at 11.16 in Q1 2026, up 34.58% year-over-year from 8.3 in Q1 2025, and up 13.01% quarter-over-quarter from 12.83 in Q4 2025.

Analysis

Dyadic International (DYAI) EV to FCF (2018 - 2026) Analysis & Trends

Dyadic International has disclosed EV to FCF across 9 years of filings, most recently posting 11.16 for Q1 2026.

  • In Q1 2026, EV to FCF rose 34.58% year-over-year to 11.16; the TTM figure through Mar 2026 stood at 3.83 (up 44.55% YoY), while the FY2025 annual figure was 3.98, up 63.13% from the prior year.
  • EV to FCF came in at 11.16 for Q1 2026 at Dyadic International, up from 12.83 in the prior quarter.
  • In the past five years, EV to FCF ranged from a high of 5387.0 in Q1 2022 to a low of 120.25 in Q2 2025.
  • Average EV to FCF over 5 years is 282.75, with a median of 22.61 recorded in 2022.
  • The largest YoY upside for EV to FCF was 8280046.18% in 2022 against a maximum downside of 100633.62% in 2022.
  • Over 5 years, EV to FCF stood at 13.37 in 2022, then plunged by 216.81% to 42.37 in 2023, then sank by 45.56% to 61.67 in 2024, then jumped by 79.19% to 12.83 in 2025, then increased by 13.01% to 11.16 in 2026.
  • Per Business Quant data, the three most recent EV to FCF figures were 11.16 in Q1 2026, 12.83 in Q4 2025, and 15.77 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Dyadic International 17.78 Mn 9.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.16
Dec 31, 2025 -12.83
Sep 30, 2025 -15.77
Jun 30, 2025 -120.25
Mar 31, 2025 -17.07
Dec 31, 2024 -61.67
Sep 30, 2024 -103.70
Jun 30, 2024 -17.07
Mar 31, 2024 -32.98
Dec 31, 2023 -42.37
Sep 30, 2023 -24.03
Jun 30, 2023 -27.48
Mar 31, 2023 -18.08
Dec 31, 2022 -13.37
Sep 30, 2022 -22.61
Jun 30, 2022 -39.75
Mar 31, 2022 5,387.00
Dec 31, 2021 -40.73
Sep 30, 2021 -30.77
Jun 30, 2021 0.04